An obsevation re Eftiligomab alfa

  1. 26,033 Posts.
    lightbulb Created with Sketch. 1469
    We are getting near the pointy end of research into Efti's effectiveness in assisting treatment for various cancer indications....
    In combination with keytruda it is showing better results with more successful outcomes for patients than keytruda alone
    in trials conducted sofar....Even signs of a combo that can negate the need for chemotherapy in certrain cases....
    To be brutally honest, there is gonna need to be a major reversal in trial data over the next few months for Efti to fall over...
    We have much to look forward to here and to be honest once again there is cause for confidence...
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
23.0¢
Change
-0.010(4.17%)
Mkt cap ! $337.6M
Open High Low Value Volume
24.0¢ 24.0¢ 23.0¢ $244.5K 1.043M

Buyers (Bids)

No. Vol. Price($)
20 392012 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 126850 6
View Market Depth
Last trade - 16.10pm 12/09/2025 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.